Suven Life Sciences standalone net profit rises 19.54% in the September 2017 quarter

Capital Market 

Sales decline 9.91% to Rs 104.10 crore

Net profit of rose 19.54% to Rs 31.75 crore in the quarter ended September 2017 as against Rs 26.56 crore during the previous quarter ended September 2016. Sales declined 9.91% to Rs 104.10 crore in the quarter ended September 2017 as against Rs 115.55 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales104.10115.55 -10 OPM %43.2331.92 -PBDT49.1942.40 16 PBT43.8537.85 16 NP31.7526.56 20

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Sat, November 11 2017. 16:24 IST